Article
Clinical implementation of plasma EGFR T790M testing using droplet digital PCR in TKI-resistant NSCLC patients.
Experimental and molecular pathology - 1 Oct 2020
Chan Dana Leng Hui, Toh Grace Li Xian, Goh Liuh Ling
Abstract excerpt
BACKGROUND: Majority of non-small cell lung cancer (NSCLC) patients progressed on epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) due to acquired T790M mutation. Blood sample is increasingly used in clinical setting for EGFR T790M detection and our laboratory employed the droplet digital PCR (ddPCR) methodology for testing. This study investigated the positive rate, specimen type for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
